Archive for 2013

Treatment for Rett Syndrome Moves a Step Closer as Rett Syndrome…

The Rett Syndrome Research Trust (RSRT) affirmed its mission to drive innovative science by awarding $4.2 million in 2012. This amount represents the largest research commitment in a given year ever…(PRWeb February 14, 2013)Read the full story at …


Non Invasive Bed Bug Treatments Offered to a State Library Shutdown…

Sighting of bed bugs in one Michigan public library forced its closure. My Cleaning Products suggested the use of the pesticide-exempt Bed Bug Bully and even offered a complimentary sample of the…(PRWeb February 14, 2013)Read the full story at htt…


Plastics Color Corp. Announces Custom-Blended Antimicrobials for…

PCC (Plastics Color Corporation), introduces MicroBlok™ antimicrobial formulations for polymers, engineered to impede the growth of a wide spectrum of microorganisms on various plastic surfaces.

(PRWeb February 14, 2013)

Read the full story at http://www.prweb.com/releases/2013/2/prweb10425800.htm


University of Colorado Cancer Center Study Shows the Preferred Feeding…

Parents and pediatric patients prefer IV feeding over tube feeding, despite medical benefits of tube feeding.(PRWeb February 13, 2013)Read the full story at http://www.prweb.com/releases/2013/2/prweb10429284.htm


zuChem and Godavari Partner to Commercialize Renewable Manufacturing…

zuChem Inc. and Godavari Biorefineries Ltd. announced they have entered into a global partnership combining zuChem’s xylitol technology platform with Godavari’s leadership position in the production…

(PRWeb February 13, 2013)

Read the full story at http://www.prweb.com/releases/2013/2/prweb10427940.htm


zuChem and Godavari Partner to Commercialize Renewable Manufacturing…

zuChem Inc. and Godavari Biorefineries Ltd. announced they have entered into a global partnership combining zuChem’s xylitol technology platform with Godavari’s leadership position in the production…

(PRWeb February 13, 2013)

Read the full story at http://www.prweb.com/releases/2013/2/prweb10427940.htm